Endpoints News Dec 30, 2025 Verastem axes Phase 1/2 lung cancer trial of Avmapki, pivots to KRAS blocker
Endpoints News Dec 29, 2025 Federal judge blocks 340B drug pricing pilot ahead of Jan. 1 effective date
Endpoints News Dec 29, 2025 ASK Pharm makes China rights deal; Unicycive resubmits kidney drug after CRL
Endpoints News Dec 29, 2025 As gene editing tools multiply, the hunt for the final technology continues
Endpoints News Dec 26, 2025 Biohaven’s ion channel drug fails again, this time in major depressive disorder
Endpoints News Dec 24, 2025 Sanofi to buy hepatitis B vaccine maker Dynavax for $2.2B; gets CRL for MS drug